Algo version: 0.98b
NBIX is listed at the NASDAQ Exchange
NBIX [NBIX]
NASDAQ Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is NBIX stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Neurocrine Biosciences 10 years ago, but if you had invested on Monday 8th of September 2014 when the price was $16.12, you would have made a profit of $104.06 per share or 645.53%

Yes, the average daily trading liquidity for Neurocrine Biosciences is $118.45 million. You should therefore be able to get in and out of your positions relatively fast.

Neurocrine Biosciences has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 1.18, the company's ability to pay off the debt is good. Neurocrine Biosciences has a good net profit margin of 18.65% and should have high tolerances against inflation.

We have calculated the inflation risk for Neurocrine Biosciences to be low [0.25 out of 1]